NAPOLI-1: Randomized Phase 3 Study of MM-398 (NAL-IRI), with or Without 5-Fluorouracil and Leucovorin, Versus 5-Fluorouracil and Leucovorin, in Metastatic Pancreatic Cancer Progressed on or Following Gemcitabine-Based Therapy

D. Von Hoff; C.P. Li; A. Wang-Gillam; G. Bodoky; A. Dean; G. Jameson; T. Macarulla; K.H. Lee; D. Cunningham; J.F. Blanc; R. Hubner; C.F. Chiu; G. Schwartsmann; J. Siveke; F. Braiteh; V. Moyo; B. Belanger; N. Dhindsa; E. Bayever; L.T. Chen

Journal ArticleOPEN ACCESS

NAPOLI-1: Randomized Phase 3 Study of MM-398 (NAL-IRI), with or Without 5-Fluorouracil and Leucovorin, Versus 5-Fluorouracil and Leucovorin, in Metastatic Pancreatic Cancer Progressed on or Following Gemcitabine-Based Therapy

Von Hoff D
Li C
Wang-Gillam A
et al.

Annals of Oncology (2014) 25 ii105

DOI: 10.1093/annonc/mdu193.3

N/ACitations

37Readers

Abstract

Von Hoff D, Li CP, Wang-Gillam A, Bodoky G, Dean A, Jameson G,et al. progressed on NAPOLI-1: randomized phase 3 study of MM-398 (NAL-IRI),with or without 5-fluorouracil and leucovorin, versus 5-fluorouraciland leucovorin, in metastatic pancreatic canceror fol-lowing gemcitabine-based therapy. Ann Oncol 2014;25:ii105–17.

Cite

CITATION STYLE

APA

Von Hoff, D., Li, C. P., Wang-Gillam, A., Bodoky, G., Dean, A., Jameson, G., … Chen, L. T. (2014). NAPOLI-1: Randomized Phase 3 Study of MM-398 (NAL-IRI), with or Without 5-Fluorouracil and Leucovorin, Versus 5-Fluorouracil and Leucovorin, in Metastatic Pancreatic Cancer Progressed on or Following Gemcitabine-Based Therapy. Annals of Oncology, 25, ii105. https://doi.org/10.1093/annonc/mdu193.3

NAPOLI-1: Randomized Phase 3 Study of MM-398 (NAL-IRI), with or Without 5-Fluorouracil and Leucovorin, Versus 5-Fluorouracil and Leucovorin, in Metastatic Pancreatic Cancer Progressed on or Following Gemcitabine-Based Therapy

Abstract

Cite

Register to see more suggestions